Cenobamate and Chlorpromazine interaction
Cenobamate and Chlorpromazine: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.
Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.
What the FDA labels say
From the Cenobamate (Xcopri) label · effective 2025-08-25
Concomitant use with other CNS depressants or alcohol may have additive effects.
Patients should be carefully observed for signs of central nervous system (CNS) depression, such as somnolence and sedation, when XCOPRI is used with other drugs with sedative properties because of potential additive effects.
CNS Depressants and Alcohol Concomitant use of XCOPRI with other CNS depressants, including alcohol, may increase the risk of neurological adverse reactions, including sedation and somnolence [see Warnings and Precautions ( 5.5 )] .
From the Chlorpromazine (Chlorpromazine Hydrochloride) label · effective 2026-02-02
Therefore, dosage of anticonvulsants, including barbiturates, should not be reduced if chlorpromazine is started.
Chlorpromazine may lower the convulsive threshold; dosage adjustments of anticonvulsants may be necessary.
Note: Chlorpromazine does not intensify the anticonvulsant action of barbiturates.
Potentiation of anticonvulsant effects does not occur.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.